Does Barclays own AXSM stock?

Yes. As of its Q3 2026 13F, Barclays holds 35,125 shares of AXSM (Axsome Therapeutics), worth $6.5M.

How many shares of AXSM does Barclays own?

As of its Q3 2026 13F, Barclays holds 35,125 shares of AXSM (Axsome Therapeutics).

As of its Q3 2026 13F, Barclays' AXSM position is worth $6.5M.

In Q3 2026, Barclays reduced its AXSM position by 16,078 shares (-31.4%).

Barclays already held AXSM in its Q4 2018 13F, the earliest on record, and has listed it in 27 quarterly 13F filings.

29 quarters

Position history for Barclays plc's holdings in Axsome Therapeutics, Inc.

Current Value

$6.5M

Current Shares

35,125

Total Value Change

+$6.4M

Total Shares Change

+24,625

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Decreased	35,125	-31.4%	$6.5M	0.0%	$184.39	0
2026-Q2	Increased	51,203	+49.5%	$12.5M	0.0%	$244.77	39
2026-Q1	Decreased	34,261	-55.4%	$5.8M	0.0%	$169.02	0
2025-Q4	Increased	76,853	+6.6%	$14M	0.0%	$182.64	30
2025-Q3	Decreased	72,067	-26.1%	$8.8M	0.0%	$121.45	0
2025-Q2	Increased	97,490	+88.0%	$10.2M	0.0%	$104.39	43
2025-Q1	Decreased	51,870	-47.1%	$6M	0.0%	$116.63	0
2024-Q4	Increased	97,988	+58.6%	$8.3M	0.0%	$84.61	39
2024-Q3	Increased	61,785	+279.6%	$5.6M	0.0%	$89.87	44
2024-Q2	Decreased	16,276	-92.6%	$1.3M	0.0%	$80.50	0
2024-Q1	Increased	220,098	+14.7%	$17.6M	0.0%	$79.80	32
2023-Q4	Increased	191,862	+1041.4%	$15.3M	0.0%	$79.59	45
2023-Q3	Increased	16,810	+229x	$1.2M	0.0%	$69.89	41
2023-Q2	New	73	-	$5,246	0.0%	$71.86	23
2022-Q4	Exited	0	-100.0%	$0	0.0%	$77.13	0
2022-Q3	New	26,572	-	$1.2M	0.0%	$44.62	35
2021-Q4	Exited	0	-100.0%	$0	0.0%	$37.78	0
2021-Q3	Decreased	1,571	-97.1%	$52,000	0.0%	$32.96	0
2021-Q2	Increased	53,717	+53.3%	$3.6M	0.0%	$67.46	37
2021-Q1	Increased	35,036	+206.5%	$2M	0.0%	$56.62	42
2020-Q4	Unchanged	11,432	0.0%	$931,000	0.0%	$81.47	0
2020-Q3	Decreased	11,432	-35.8%	$815,000	0.0%	$71.25	0
2020-Q2	Decreased	17,793	-48.4%	$1.5M	0.0%	$82.28	0
2020-Q1	Decreased	34,471	-47.3%	$2M	0.0%	$58.83	0
2019-Q4	Increased	65,438	+554.4%	$6.8M	0.0%	$103.36	44
2019-Q3	Decreased	10,000	-78.1%	$202,000	0.0%	$20.24	0
2019-Q2	Increased	45,660	+260x	$1.2M	0.0%	$25.75	41
2019-Q1	Decreased	175	-98.3%	$2,000	0.0%	$14.23	0
2018-Q4	First report	10,500	-	$30,000	0.0%	$2.82	0